Richard William Scalzo - 15 Nov 2023 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Senior Vice President, Head of Finance and Administration
Signature
/s/ Richard Scalzo
Issuer symbol
DYN
Transactions as of
15 Nov 2023
Net transactions value
$0
Form type
4
Filing time
16 Nov 2023, 16:35:22 UTC
Previous filing
20 Sep 2023
Next filing
06 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DYN Common Stock Award $0 +89,742 +220% $0.000000 130,537 15 Nov 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DYN Stock Option (right to buy) Award $0 +34,946 $0.000000 34,946 15 Nov 2023 Common Stock 34,946 $10.88 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of Common Stock issuable under 89,742 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on February 15, 2024.
F2 Includes 127,193 unvested RSUs.
F3 This option was granted on November 15, 2023. The shares underlying the option are scheduled to vest over four years in equal monthly installments through November 15, 2027.

Remarks:

Senior Vice President, Head of Finance and Administration